Literature DB >> 6405286

MAO-B inhibitor deprenyl and beta-phenylethylamine potentiate [D-ALA2]-Met-enkephalinamide-induced seizures.

O E Ukponmwan, A L van der Poel-Heisterkamp, J Haffmans, M Dzoljic.   

Abstract

The relationship between deprenyl (MAO-B inhibitor), beta-phenylethylamine (PEA, MAO-B substrate) and [D-Ala2]-Met-enkephalinamide (DALA)-induced seizure was studied in the urethane-anaesthetized rats. A combined electromyographic (EMG) and electrocorticographic (ECoG) method was used. PEA (20-100 micrograms ivt) or DALA (10 micrograms ivt) induced myoclonic contractions (MC) in the submandibular muscle and epileptiform pattern with spike activity in the ECoG. Administration of subconvulsant doses of PEA (5-10 micrograms ivt 0.5-1 min before DALA) significantly increased DALA-induced seizure activity. Similarly, blockade of MAO-B with deprenyl (3-48 mg/kg ip) also enhanced DALA-induced epileptiform pattern. It is evident from this study that MAO-B system significantly modulates the excitatory phenomena induced by DALA. These findings of interactions between MAO-B system and enkephalinergic one, might be of relevance in the clinical situations such as psychosis, stress, a use of tricyclic antidepressants and all other cases, where the alteration of MAO-B system is a part of disease or induced during drug therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405286     DOI: 10.1007/BF00649350

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

1.  A model for the quantitative study of central dopaminergic and serotoninergic activity.

Authors:  D Bieger; L Larochelle; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1972-04       Impact factor: 4.432

2.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

Authors:  J P Johnston
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

3.  Serotonergic properties of beta-phenethylamine in rats.

Authors:  R S Sloviter; J D Connor; E G Drust
Journal:  Neuropharmacology       Date:  1980-11       Impact factor: 5.250

4.  Phenylethylamine effects on dopamine synthesis. Structure-activity relationships.

Authors:  R L Patrick
Journal:  Biochem Pharmacol       Date:  1981-01-15       Impact factor: 5.858

5.  Does phenylethylamine cause schizophrenia?

Authors:  M Sandler; G P Reynolds
Journal:  Lancet       Date:  1976-01-10       Impact factor: 79.321

6.  Excretion of beta-phenethylamine is elevated in humans after profound stress.

Authors:  M A Paulos; R E Tessel
Journal:  Science       Date:  1982-02-26       Impact factor: 47.728

7.  Phenylethylamine in paranoid chronic schizophrenia.

Authors:  S G Potkin; F Karoum; L W Chuang; H E Cannon-Spoor; I Phillips; R J Wyatt
Journal:  Science       Date:  1979-10-26       Impact factor: 47.728

  7 in total
  1 in total

1.  An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations.

Authors:  O E Ukponmwan; J Rupreht; M Dzoljic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.